CONMED Corporation (CNMD) - Cash Flow Conversion Efficiency
Based on the latest financial reports, CONMED Corporation (CNMD) has a cash flow conversion efficiency ratio of 0.013x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($13.47 Million) by net assets ($1.02 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see CONMED Corporation market cap and net worth for the company's overall valuation and market capitalisation.
CONMED Corporation - Cash Flow Conversion Efficiency Trend (1990–2025)
This chart illustrates how CONMED Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data.
CONMED Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of CONMED Corporation ranked by their cash flow conversion efficiency. Explore CONMED Corporation (CNMD) cash earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Reysas Tasimacilik ve Lojistik Ticaret AS
IS:RYSAS
|
0.040x |
|
Malaysia Building Society Bhd
KLSE:1171
|
0.006x |
|
Fujian Nebula Electronics Co Ltd
SHE:300648
|
0.006x |
|
Changsha DIALINE New Material Sci & Tech Co Ltd
SHE:300700
|
-0.041x |
|
Tansun Technology Co Ltd
SHE:300872
|
0.019x |
|
Shanghai Aladdin Biochemical Technology Co. Ltd. A
SHG:688179
|
N/A |
|
Wuxi Online Offline Communication Information Technology Co. Ltd.
SHE:300959
|
N/A |
|
Shaanxi Heimao Coking Co Ltd
SHG:601015
|
0.086x |
Annual Cash Flow Conversion Efficiency for CONMED Corporation (1990–2025)
The table below shows the annual cash flow conversion efficiency of CONMED Corporation from 1990 to 2025. View current stock price of CONMED Corporation for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $1.03 Billion | $170.69 Million | 0.165x | -4.74% |
| 2024-12-31 | $962.68 Million | $166.97 Million | 0.173x | +15.43% |
| 2023-12-31 | $834.22 Million | $125.35 Million | 0.150x | +235.75% |
| 2022-12-31 | $745.54 Million | $33.37 Million | 0.045x | -68.55% |
| 2021-12-31 | $785.43 Million | $111.77 Million | 0.142x | +56.36% |
| 2020-12-31 | $709.04 Million | $64.53 Million | 0.091x | -32.03% |
| 2019-12-31 | $710.47 Million | $95.13 Million | 0.134x | +18.71% |
| 2018-12-31 | $662.27 Million | $74.70 Million | 0.113x | +8.63% |
| 2017-12-31 | $631.43 Million | $65.57 Million | 0.104x | +57.72% |
| 2016-12-31 | $580.58 Million | $38.22 Million | 0.066x | -19.87% |
| 2015-12-31 | $585.07 Million | $48.07 Million | 0.082x | -26.72% |
| 2014-12-31 | $581.30 Million | $65.18 Million | 0.112x | -16.02% |
| 2013-12-31 | $606.32 Million | $80.95 Million | 0.134x | -14.87% |
| 2012-12-31 | $607.00 Million | $95.20 Million | 0.157x | -12.73% |
| 2011-12-31 | $573.07 Million | $102.99 Million | 0.180x | +175.65% |
| 2010-12-31 | $586.56 Million | $38.24 Million | 0.065x | +50.18% |
| 2009-12-31 | $576.51 Million | $25.03 Million | 0.043x | -62.25% |
| 2008-12-31 | $531.73 Million | $61.15 Million | 0.115x | -11.87% |
| 2007-12-31 | $505.00 Million | $65.89 Million | 0.130x | -11.02% |
| 2006-12-31 | $440.35 Million | $64.57 Million | 0.147x | +56.54% |
| 2005-12-31 | $453.01 Million | $42.43 Million | 0.094x | -43.93% |
| 2004-12-31 | $447.98 Million | $74.84 Million | 0.167x | +24.84% |
| 2003-12-31 | $433.49 Million | $58.01 Million | 0.134x | +15.27% |
| 2002-12-31 | $386.94 Million | $44.92 Million | 0.116x | -57.32% |
| 2001-12-31 | $283.63 Million | $77.15 Million | 0.272x | +74.48% |
| 2000-12-31 | $230.60 Million | $35.95 Million | 0.156x | -10.97% |
| 1999-12-31 | $211.30 Million | $37.00 Million | 0.175x | +51.93% |
| 1998-12-31 | $182.20 Million | $21.00 Million | 0.115x | -41.03% |
| 1997-12-31 | $162.70 Million | $31.80 Million | 0.195x | +19.69% |
| 1996-12-31 | $158.60 Million | $25.90 Million | 0.163x | +140.15% |
| 1995-12-31 | $75.00 Million | $5.10 Million | 0.068x | -64.69% |
| 1994-12-31 | $43.10 Million | $8.30 Million | 0.193x | +26.69% |
| 1993-12-31 | $37.50 Million | $5.70 Million | 0.152x | +63.40% |
| 1992-12-31 | $38.70 Million | $3.60 Million | 0.093x | +125.91% |
| 1991-12-31 | $34.00 Million | $1.40 Million | 0.041x | -89.86% |
| 1990-12-31 | $12.80 Million | $5.20 Million | 0.406x | -- |
About CONMED Corporation
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation an… Read more